Literature DB >> 34913555

Phenotypic similarities within the morphologic spectrum of DICER1-associated sarcomas and pleuropulmonary blastoma: Histopathologic features guide diagnosis in the LMIC setting.

Paromita Roy1, Anirban Das2, Angad Singh1, Joyshree Panda1, Arpita Bhattacharya2, Anisha Gehani3, Mayur Parihar4, Reghu K S2, Rimpa Achari5, Rita Alaggio6,7,8, Amanda Field9, D Ashley Hill9,10, Louis P Dehner11, Kris Ann P Schultz12.   

Abstract

Extrapulmonary DICER1-associated sarcomas (DS) can harbor morphological features overlapping with pleuropulmonary blastoma. We report three children with intracranial and genital tract sarcomas, suspected to have DS based on a heterogeneous yet defining combination of spindle-cell sarcomatous and blastemal morphology, with rhabdomyomatous differentiation. Foci of immature cartilage at diagnosis (n = 2/3) and increased neuroepithelial differentiation at recurrence (n = 1) were noted. Morphological suspicion prompted somatic testing at reference centers, confirming likely biallelic, loss-of-function, and "hotspot" missense DICER1 variants in all three tumors. This can serve as a model for this diagnosis in resource-limited settings and has implications for germline testing, surveillance, and tumor management.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  DICER1 syndrome; DICER1-associated sarcoma; rhabdomyosarcoma

Mesh:

Substances:

Year:  2021        PMID: 34913555      PMCID: PMC9248686          DOI: 10.1002/pbc.29466

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.838


  23 in total

1.  Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.

Authors:  Christian Koelsche; Martin Mynarek; Daniel Schrimpf; Luca Bertero; Jonathan Serrano; Felix Sahm; David E Reuss; Yanghao Hou; Daniel Baumhoer; Christian Vokuhl; Uta Flucke; Iver Petersen; Wolfgang Brück; Stefan Rutkowski; Sandro Casavilca Zambrano; Juan Luis Garcia Leon; Rosdali Yesenia Diaz Coronado; Manfred Gessler; Oscar M Tirado; Jaume Mora; Javier Alonso; Xavier Garcia Del Muro; Manel Esteller; Dominik Sturm; Jonas Ecker; Till Milde; Stefan M Pfister; Andrey Korshunov; Matija Snuderl; Gunhild Mechtersheimer; Ulrich Schüller; David T W Jones; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-06-07       Impact factor: 17.088

2.  Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.

Authors:  Gianni Bisogno; Gian Luca De Salvo; Christophe Bergeron; Soledad Gallego Melcón; Johannes H Merks; Anna Kelsey; Helene Martelli; Veronique Minard-Colin; Daniel Orbach; Heidi Glosli; Julia Chisholm; Michela Casanova; Ilaria Zanetti; Christine Devalck; Myriam Ben-Arush; Peter Mudry; Sima Ferman; Meriel Jenney; Andrea Ferrari
Journal:  Lancet Oncol       Date:  2019-09-24       Impact factor: 41.316

3.  DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.

Authors:  Leslie Doros; Jiandong Yang; Louis Dehner; Christopher T Rossi; Kerry Skiver; Jason A Jarzembowski; Yoav Messinger; Kris Ann Schultz; Gretchen Williams; Nicolas André; D Ashley Hill
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

4.  Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.

Authors:  W Glenn McCluggage; Maria Apellaniz-Ruiz; Anne-Laure Chong; Krisztina Z Hanley; Jose E Velázquez Vega; Terri P McVeigh; William D Foulkes
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.394

5.  DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor.

Authors:  Junne Kamihara; Vera Paulson; Micheál A Breen; Theodore W Laetsch; Dinesh Rakheja; David S Shulman; Michelle L Schoettler; Catherine M Clinton; Abigail Ward; Deirdre Reidy; R Seth Pinches; Daniel A Weiser; Elizabeth A Mullen; Jaclyn Schienda; Paul A Meyers; Steven G DuBois; Jonathan A Nowak; William D Foulkes; Kris Ann P Schultz; Katherine A Janeway; Sara O Vargas; Alanna J Church
Journal:  Mod Pathol       Date:  2020-04-14       Impact factor: 7.842

6.  Gain of chromosome 8q is a frequent finding in pleuropulmonary blastoma.

Authors:  Ronald R de Krijger; Sandra M H Claessen; Frieda van der Ham; Ad J M van Unnik; Christina A Hulsbergen-van de Kaa; Leen van Leuven; Max van Noesel; Ernst J M Speel
Journal:  Mod Pathol       Date:  2007-09-14       Impact factor: 7.842

7.  DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.

Authors:  Gregor Krings; Karuna Garg; Gregory R Bean; Joshua Anderson; Ankur R Sangoi
Journal:  Mod Pathol       Date:  2018-09-28       Impact factor: 7.842

8.  The Value of DICER1 Mutation Analysis in "Subtle" Diagnostically Challenging Embryonal Rhabdomyosarcomas of the Uterine Cervix.

Authors:  Ju-Yoon Yoon; Maria Apellaniz-Ruiz; Anne-Laure Chong; Zena Slim; Stuart G Salfinger; Blaise A Clarke; Colin J R Stewart; William D Foulkes; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-09-01       Impact factor: 2.762

9.  Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation.

Authors:  Yoshiko Nakano; Daiichiro Hasegawa; Douglas R Stewart; Kris Ann P Schultz; Anne K Harris; Junko Hirato; Suguru Uemura; Akihiro Tamura; Atsuro Saito; Atsufumi Kawamura; Makiko Yoshida; Kai Yamasaki; Satoshi Yamashita; Toshikazu Ushijima; Yoshiyuki Kosaka; Koichi Ichimura; Louis P Dehner; D Ashley Hill
Journal:  Mod Pathol       Date:  2019-07-11       Impact factor: 7.842

10.  Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome.

Authors:  Jorge Melendez-Zajgla; Gabriela E Mercado-Celis; Javier Gaytan-Cervantes; Amada Torres; Nayeli Belem Gabiño; Martha Zapata-Tarres; Luis Enrique Juarez-Villegas; Pablo Lezama; Vilma Maldonado; Karen Ruiz-Monroy; Elvia Mendoza-Caamal
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.